Cooperativity of oncogenic K-ras and downregulated p16/INK4A in human pancreatic tumorigenesis.
about
Phosphorylated Ribosomal Protein S6 Is Required for Akt-Driven Hyperplasia and Malignant Transformation, but Not for Hypertrophy, Aneuploidy and Hyperfunction of Pancreatic β-CellsGenomic profiling guides the choice of molecular targeted therapy of pancreatic cancer.Decreased TUSC3 Promotes Pancreatic Cancer Proliferation, Invasion and MetastasisAn angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis.Redox Regulation of Stem-like Cells Though the CD44v-xCT Axis in Colorectal Cancer: Mechanisms and Therapeutic ImplicationsMutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal adenocarcinoma.Melatonin overcomes gemcitabine resistance in pancreatic ductal adenocarcinoma by abrogating nuclear factor-κB activation.Targeting reactive oxygen species in development and progression of pancreatic cancer.Expression of the tumor suppressor gene p16, and lymph node metastasis in patients with ovarian cancer.SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer.Cadmium Exposure as a Putative Risk Factor for the Development of Pancreatic Cancer: Three Different Lines of Evidence.Inhibition of enhancer of zeste homolog 2 increases the expression of p16 and suppresses the proliferation and migration of ovarian carcinoma cells in vitro and in vivo.dNTP metabolism links mechanical cues and YAP/TAZ to cell growth and oncogene-induced senescence.
P2860
Q28550394-8D5B45EE-8A58-4CD1-BE48-FD7B0A63F00DQ35671422-4E38D8B7-3B83-4A57-A2E6-E445D459456BQ35922334-6AC6D215-ED7B-4C70-BFD7-8CEE28C80953Q35955457-F8593961-7EF5-4892-9E3C-F0FCDE7BFB0DQ36970375-B3391DCD-B1FF-4245-831A-A790EC761350Q37676353-AC81BB68-365D-4769-ABCC-21C0F97BE748Q38829774-AC349419-288A-4967-826E-532F4D5807F3Q39007517-A1118B17-F40E-421D-8EFA-2C103E01BDE6Q41297705-C56356E8-EBBE-4790-998F-5BEB7B12C96FQ47616426-38600EB1-6A18-4213-B0E8-0E9AE5125A34Q48213786-DD9BB1C2-ACF9-41E9-8ADB-62861D9D2981Q49777893-0EB280A8-2BF1-4ACC-9C0F-3E3FDDBDC5FCQ53695910-989A2658-CCA1-4224-A898-D646AF221E20
P2860
Cooperativity of oncogenic K-ras and downregulated p16/INK4A in human pancreatic tumorigenesis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cooperativity of oncogenic K-r ...... uman pancreatic tumorigenesis.
@ast
Cooperativity of oncogenic K-r ...... uman pancreatic tumorigenesis.
@en
type
label
Cooperativity of oncogenic K-r ...... uman pancreatic tumorigenesis.
@ast
Cooperativity of oncogenic K-r ...... uman pancreatic tumorigenesis.
@en
prefLabel
Cooperativity of oncogenic K-r ...... uman pancreatic tumorigenesis.
@ast
Cooperativity of oncogenic K-r ...... uman pancreatic tumorigenesis.
@en
P2093
P2860
P1433
P1476
Cooperativity of oncogenic K-r ...... uman pancreatic tumorigenesis.
@en
P2093
Huaiqiang Ju
Huamin Wang
James W Freeman
Jason B Fleming
Jianhua Ling
Paul J Chiao
Peng Huang
Zhongkui Li
P2860
P304
P356
10.1371/JOURNAL.PONE.0101452
P407
P577
2014-07-16T00:00:00Z